• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1% 环吡酮胺乳膏。其抗菌活性及治疗用途的初步综述。

Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.

作者信息

Jue S G, Dawson G W, Brogden R N

出版信息

Drugs. 1985 Apr;29(4):330-41. doi: 10.2165/00003495-198529040-00002.

DOI:10.2165/00003495-198529040-00002
PMID:3158508
Abstract

Ciclopirox olamine is a substituted pyridone antimycotic, unrelated to the imidazole derivatives, with activity against a broad spectrum of dermatophytes, yeasts, actinomycetes, molds, other fungi, and a variety of Gram-positive and Gram-negative bacteria. The efficacy of ciclopirox olamine cream has been demonstrated in open and placebo-controlled studies in patients with superficial dermatophyte or yeast infections, and in double-blind comparative trials in patients with dermatomycoses, topical ciclopirox olamine was comparable to or better than clotrimazole in efficacy and caused a similar number of side effects. Ciclopirox olamine penetrates through fingernails and in preliminary studies has been successfully used in onychomycoses. However, further studies are needed to establish the role of ciclopirox in the treatment of onychomycoses and dermatomycoses relative to that of the more recently introduced antigungal agents.

摘要

环吡酮胺是一种取代吡啶酮类抗真菌药,与咪唑衍生物无关,对多种皮肤癣菌、酵母菌、放线菌、霉菌、其他真菌以及多种革兰氏阳性和革兰氏阴性细菌具有活性。在开放性和安慰剂对照研究中,已证实环吡酮胺乳膏对浅表皮肤癣菌或酵母菌感染患者有效;在皮肤真菌病患者的双盲对比试验中,局部使用环吡酮胺在疗效上与克霉唑相当或更佳,且副作用数量相似。环吡酮胺可穿透指甲,在初步研究中已成功用于治疗甲癣。然而,相对于最近推出的抗真菌药物,还需要进一步研究以确定环吡酮在治疗甲癣和皮肤真菌病中的作用。

相似文献

1
Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.1% 环吡酮胺乳膏。其抗菌活性及治疗用途的初步综述。
Drugs. 1985 Apr;29(4):330-41. doi: 10.2165/00003495-198529040-00002.
2
Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.环吡酮胺:作为一种局部抗真菌药物,其近期的非临床和临床数据。
Drugs. 2010 Nov 12;70(16):2133-52. doi: 10.2165/11538110-000000000-00000.
3
A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis.环吡酮胺(8% 倍佳)治疗甲癣的临床与实验室研究
Chin Med Sci J. 1991 Sep;6(3):166-8.
4
Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis.一种新型抗真菌乳膏(1%环吡酮胺)治疗皮肤念珠菌病的疗效评估。
Clin Ther. 1985;8(1):41-8.
5
Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.1%环吡酮胺洗剂:与1%环吡酮胺乳膏的生物等效性及足癣临床疗效
Clin Ther. 1989 May-Jun;11(3):290-303.
6
The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.将抗真菌药物环吡酮胺重新定位为治疗血液恶性肿瘤的新型治疗药物。
J Clin Pharm Ther. 2011 Apr;36(2):128-34. doi: 10.1111/j.1365-2710.2010.01172.x. Epub 2010 Aug 24.
7
Ciclopirox for the treatment of superficial fungal infections: a review.环吡酮治疗浅表真菌感染的综述
Int J Dermatol. 2003 Sep;42 Suppl 1:3-9. doi: 10.1046/j.1365-4362.42.s1.2.x.
8
Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.噻康唑。对其抗微生物活性及在浅部真菌病治疗应用的综述。
Drugs. 1986 Jan;31(1):29-51. doi: 10.2165/00003495-198631010-00003.
9
Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.环吡酮胺、盐酸布替萘芬和硝酸益康唑对皮肤癣菌、酵母菌和细菌的体外活性评估。
Int J Dermatol. 2003 Sep;42 Suppl 1:11-7. doi: 10.1046/j.1365-4362.42.s1.4.x.
10
Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: multicenter, double-blind comparative studies.
Clin Ther. 1985;7(4):409-17.

引用本文的文献

1
Ciclopirox suppresses poxvirus replication by targeting iron metabolism.环吡酮通过靶向铁代谢来抑制痘病毒复制。
bioRxiv. 2025 Jul 24:2025.07.24.666650. doi: 10.1101/2025.07.24.666650.
2
In Vitro Ciclopirox Glucuronidation in Liver Microsomes from Humans and Various Experimental Animals.人及各种实验动物肝微粒体中环吡酮葡胺的体外葡萄糖醛酸化。
Eur J Drug Metab Pharmacokinet. 2024 Sep;49(5):619-629. doi: 10.1007/s13318-024-00907-2. Epub 2024 Jul 11.
3
Metal-Free Cascade Formation of C-C and C-N Bond for the Construction of 3-Cyano-2-Pyridones with Insecticidal Properties.

本文引用的文献

1
Amino acid transport in yeast and effects of nystatin.酵母中的氨基酸转运及制霉菌素的作用。
Can J Biochem Physiol. 1963 Feb;41:397-407.
2
[A comparative double blind trial with vaginal creams of cyclopyroxolamine and miconazole in vulvovaginal candidosis (author's transl)].
Mykosen. 1981 Dec;24(12):721-30.
3
[Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration].
Arzneimittelforschung. 1981;31(8A):1337-53.
4
用于构建具有杀虫特性的3-氰基-2-吡啶酮的C-C和C-N键的无金属级联形成
Molecules. 2024 Jun 12;29(12):2792. doi: 10.3390/molecules29122792.
4
The Plant Defensin Ppdef1 Is a Novel Topical Treatment for Onychomycosis.植物防御素Ppdef1是一种治疗甲癣的新型局部用药。
J Fungi (Basel). 2023 Nov 17;9(11):1111. doi: 10.3390/jof9111111.
5
Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.环吡酮通过信号转导和转录激活因子3(STAT3)诱导胃癌细胞生长停滞和自噬性细胞死亡。
Cell Death Dis. 2022 Nov 28;13(11):1007. doi: 10.1038/s41419-022-05456-7.
6
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.地拉罗司:一种具有 40 年历史的多靶点药物,可能对 COVID-19 和具有相似症状的疾病具有活性。
Int J Mol Sci. 2022 Jun 16;23(12):6735. doi: 10.3390/ijms23126735.
7
Salvinia auriculata: chemical profile and biological activity against Staphylococcus aureus isolated from bovine mastitis.槐叶苹:对奶牛乳腺炎分离金黄色葡萄球菌的化学特征和生物活性。
Braz J Microbiol. 2021 Dec;52(4):2401-2411. doi: 10.1007/s42770-021-00595-z. Epub 2021 Aug 16.
8
Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.环吡酮胺通过激活 PERK 依赖性内质网应激诱导结直肠癌细胞死亡。
Cell Death Dis. 2020 Jul 27;11(7):582. doi: 10.1038/s41419-020-02779-1.
9
Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis.环吡酮羟丙基壳聚糖(HPCH)指甲油:其在甲真菌病治疗中的应用综述
Dermatol Ther (Heidelb). 2020 Oct;10(5):917-929. doi: 10.1007/s13555-020-00420-9. Epub 2020 Jul 23.
10
Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.铁与螯合作用在生物化学和医学中的应用:控制铁代谢和治疗相关疾病的新方法。
Cells. 2020 Jun 12;9(6):1456. doi: 10.3390/cells9061456.
[Studies on the pharmacology and toxicology of ciclopiroxolamine (author's transl)].
Arzneimittelforschung. 1981;31(8A):1328-32.
5
[Microbiological laboratory studies with ciclopiroxolamine (author's transl)].[环吡酮胺的微生物学实验室研究(作者译)]
Arzneimittelforschung. 1981;31(8A):1317-22.
6
[Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)].
Arzneimittelforschung. 1981;31(8A):1376-8.
7
[Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)].
Arzneimittelforschung. 1981;31(8A):1366-8.
8
[Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)].
Arzneimittelforschung. 1981;31(8A):1360-5.
9
[On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)].
Arzneimittelforschung. 1981;31(8A):1369-72.
10
HOE 296, a new antimycotic compound with a broad antimicrobial spectrum. Laboratory results.
Arzneimittelforschung. 1973 May;23(5):670-4.